New Targets Explored to Boost Immunotherapy in Melanoma – Targeted Oncology
|
New Targets Explored to Boost Immunotherapy in Melanoma
Targeted Oncology While PD-1, PD-L1, and CTLA-4 checkpoint inhibitors have proven to be effective in treating patients with melanoma, not all patients respond to immunotherapy. To help nonresponders, additional targets and immunotherapy strategies are being investigated … |
